Italia markets closed
FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.239,66 +153,86 (+0,40%) Nasdaq
15.927,90 +316,14 (+2,03%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
83,66 +0,09 (+0,11%) Bitcoin EUR
59.034,85 -1.237,26 (-2,05%)
DVA Jan 2025 67.500 put
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 03:47PM EDT
| Chiusura precedente | 1,6000 |
| Aperto | 1,6000 |
| Denaro | 1,0000 |
| Lettera | 2,3500 |
| Prezzo d'esercizio | 67,50 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 1,6000 - 1,6000 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 10 |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.